Skip to content

Clinical trials

Completed Lupus Erythematosus, Systemic trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Status: Completed Country / region: South Korea Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20082
20102
20113
20124
20133
20141
20151
20162
20175
20183
20193
20204
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Bristol-Myers Squibb3
Eli Lilly and Company3
AbbVie2
Corestemchemon, Inc.2
EMD Serono2
Human Genome Sciences Inc., a GSK Company2
MedImmune LLC2
Pfizer2
UCB Pharma2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic37
Autoimmune Diseases6
Lupus Erythematosus, Cutaneous3
Lupus Nephritis3
Connective Tissue Diseases1
Glomerulonephritis1
Immune System Diseases1
Kidney Diseases1
Lupus Erythematosus, Discoid1
Nephritis1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.